Research led by the University of California, Riverside, suggests that vanillin, a flavoring chemical commonly used in e-cigarettes, may interfere with normal embryonic development in pregnant women who vape. The study, published in Human Reproduction on August 12, utilized human embryonic stem cells to investigate the potential cellular effects of vanillin exposure. The researchers found that micromolar concentrations of vanillin tended to kill embryonic stem cells, while nanomolar concentrations caused cells to lose pluripotency and differentiate predominantly into endoderm, potentially disrupting normal embryonic development.
The study identified the TRPV4 channel on embryonic cell surfaces as the mechanism through which vanillin exerts its effects. Exposure to vanillin led to a rapid influx of calcium via TRPV4 activation, triggering downstream events that resulted in loss of pluripotency and biased differentiation toward endoderm. The researchers predict that nanomolar concentrations of vanillin, which can reach the embryo in pregnant women who vape, are sufficient to induce these cellular changes. Consequently, the findings suggest that women should exercise caution and consult physicians regarding vaping during pregnancy, particularly if experiencing fertility issues or miscarriages. The authors also recommend that regulators consider mandating ingredient disclosure on e-cigarette product packaging and evaluating the potential prenatal harm of these products in policy decisions. Source